Arno Therapeutics, Inc. (ARNI)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0002 (-99.50%)
At close: Jan 30, 2026
-99.00%
Market Cap 49.00
Revenue (ttm) n/a
Net Income (ttm) -13.70M
Shares Out 49.35M
EPS (ttm) -0.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 7,551
Open 0.0000
Previous Close 0.0002
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0002
Beta -16.84
RSI 38.00
Earnings Date n/a

About Arno Therapeutics

Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 4
Stock Exchange OTCMKTS
Ticker Symbol ARNI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.